Xenogeneic (bovine) peripheral blood leukocytes engrafted into severe combined immunodeficient mice retain primary immune function

Veterinary Immunology and Immunopathology
J D GreenwoodB P Wilcock

Abstract

The immune responsiveness of xenogeneic PBL engrafted into SCID mice was investigated using the bovine PBL-reconstituted SCID mouse model system (PBL-SCID-bo). Bovine PBL-reconstitution and B-cell activity were monitored by bovine serum Ig production. Bovine T-cell function was demonstrated by an antigen-specific immune response to bovine transplantation antigens provided by bovine skin allografts. Bovine allograft rejection was clearly evident in > 65% PBL-SCID-bo that received a bovine PBL inoculum either 30 days after bovine skin grafting, or 7-52 days before bovine skin grafting. Bovine allograft rejection was confirmed via histological examination and was characterized primarily by a band of infiltrating bovine lymphocytes at the periphery of the graft and tissue necrosis. A secondary immune response could be elicited if bovine cells in the PBL inoculum were presensitized to Ag from the bovine skin allograft donor. This study is the first to show that bovine cells engrafted in SCID mice after i.p. injection of bovine PBL retain some aspects of immune competency. These results confirm the value of the xenogeneic PBL-reconstituted SCID mouse model in the study of primary immunity.

References

Dec 1, 1991·Immunological Reviews·B E TorbettD E Mosier
Jun 1, 1991·Transplantation·B M Hall
Oct 4, 1990·Nature·G M Fulop, R A Phillips
Aug 1, 1970·The Journal of Experimental Medicine·J H Gordon, R Dubos
Feb 10, 1983·Nature·G C BosmaM J Bosma
Mar 1, 1982·Transplantation·D SteinmullerW J Burlingham
Sep 13, 1994·Proceedings of the National Academy of Sciences of the United States of America·A G MurrayJ S Pober

❮ Previous
Next ❯

Citations

Jul 4, 2001·Clinical Microbiology Reviews·N B Harris, R G Barletta
Aug 2, 2005·Developmental and Comparative Immunology·Yaofeng ZhaoRobert Aitken
Sep 24, 2010·Veterinary Pathology·A KreissG M Woods

❮ Previous
Next ❯

Related Concepts

Related Feeds

Allogenic & Autologous Therapies

Allogenic therapies are generated in large batches from unrelated donor tissues such as bone marrow. In contrast, autologous therapies are manufactures as a single lot from the patient being treated. Here is the latest research on allogenic and autologous therapies.